ACT Genomics and LSI Medience Sign MOU to form a Strategic Partnership and Collaborate in the Japanese Market
TOKYO, July 1, 2024 /PRNewswire/ — ACT Genomics Co. Ltd. (headquarters: Neihu District, Taipei City, Taiwan, R.O.C. , CEO: Walt Ling, hereafter ACTG), a leader in comprehensive cancer genomic profiling, and LSI Medience Corporation (headquarters:… Read More »ACT Genomics and LSI Medience Sign MOU to form a Strategic Partnership and Collaborate in the Japanese Market